摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-chloro-N-(4-chloro-3-(2-(2-(dimethylamino)ethylamino)-8-methoxy-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)phenyl)-6-(4-(4-methylpiperazin-1-yl)-benzylamino)-isonicotinamide | 1192310-15-8

中文名称
——
中文别名
——
英文名称
2-chloro-N-(4-chloro-3-(2-(2-(dimethylamino)ethylamino)-8-methoxy-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)phenyl)-6-(4-(4-methylpiperazin-1-yl)-benzylamino)-isonicotinamide
英文别名
2-chloro-N-[4-chloro-3-[2-[2-(dimethylamino)ethylamino]-8-methoxy-7-oxopyrido[2,3-d]pyrimidin-6-yl]phenyl]-6-[[4-(4-methylpiperazin-1-yl)phenyl]methylamino]pyridine-4-carboxamide
2-chloro-N-(4-chloro-3-(2-(2-(dimethylamino)ethylamino)-8-methoxy-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)phenyl)-6-(4-(4-methylpiperazin-1-yl)-benzylamino)-isonicotinamide化学式
CAS
1192310-15-8
化学式
C36H40Cl2N10O3
mdl
——
分子量
731.685
InChiKey
ICCGNSYKLBSPRC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.3
  • 重原子数:
    51
  • 可旋转键数:
    12
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    131
  • 氢给体数:
    3
  • 氢受体数:
    11

文献信息

  • RAF INHIBITORS
    申请人:BACKES Alexander
    公开号:US20110257207A1
    公开(公告)日:2011-10-20
    The present invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one. These compounds are inhibitors or kinases such as Raf, including compounds that show anti-proliferative activity, including against tumor cells, and are useful in the treatment of diseases including cancer.
    本发明提供了吡啶并[2,3-d]嘧啶-7-酮的衍生物。这些化合物是Raf等激酶的抑制剂,包括表现出抗增殖活性的化合物,包括对肿瘤细胞的抗活性,并且在治疗癌症等疾病方面是有用的。
  • Improved raf inhibitors
    申请人:Forma Therapeutics, Inc.
    公开号:EP2112150B1
    公开(公告)日:2013-10-16
  • US8232283B2
    申请人:——
    公开号:US8232283B2
    公开(公告)日:2012-07-31
  • [EN] IMPROVED RAF INHIBITORS<br/>[FR] INHIBITEURS DE RAF AMÉLIORÉS
    申请人:GPC BIOTECH AG
    公开号:WO2009130015A1
    公开(公告)日:2009-10-29
    The present invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one. These compounds are inhibitors or kinases such as Raf, including compounds that show anti-proliferative activity, including against tumor cells, and are useful in the treatment of diseases including cancer.
查看更多